Richard M. Crapper

850 total citations
19 papers, 631 citations indexed

About

Richard M. Crapper is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Epidemiology. According to data from OpenAlex, Richard M. Crapper has authored 19 papers receiving a total of 631 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Immunology, 4 papers in Radiology, Nuclear Medicine and Imaging and 3 papers in Epidemiology. Recurrent topics in Richard M. Crapper's work include T-cell and B-cell Immunology (6 papers), Immune Cell Function and Interaction (4 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Richard M. Crapper is often cited by papers focused on T-cell and B-cell Immunology (6 papers), Immune Cell Function and Interaction (4 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Richard M. Crapper collaborates with scholars based in Australia and United States. Richard M. Crapper's co-authors include John W. Schrader, Lauren Grace Mackey, Ian H. Frazer, Timothy C. Brown, Gabriele Medley, Ian Clark‐Lewis, David Deam, Peter K. Gregersen, Parvin Merryman and P. S. Bhathal and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and The Journal of Immunology.

In The Last Decade

Richard M. Crapper

19 papers receiving 585 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Richard M. Crapper Australia 13 254 197 123 99 97 19 631
S Sugai Japan 10 237 0.9× 117 0.6× 59 0.5× 123 1.2× 142 1.5× 31 592
C. J. Alcock United Kingdom 9 422 1.7× 91 0.5× 79 0.6× 105 1.1× 122 1.3× 17 774
A Puissant France 13 141 0.6× 174 0.9× 62 0.5× 85 0.9× 181 1.9× 42 641
M. Bunce United Kingdom 16 594 2.3× 178 0.9× 98 0.8× 117 1.2× 93 1.0× 29 974
S. F. Goldmann Germany 13 469 1.8× 89 0.5× 92 0.7× 113 1.1× 72 0.7× 54 863
Lorraine Beldotti United States 9 250 1.0× 97 0.5× 43 0.3× 75 0.8× 147 1.5× 13 541
Oettgen Hf United States 14 253 1.0× 70 0.4× 90 0.7× 191 1.9× 199 2.1× 30 719
Mitsuo Okubo Japan 13 401 1.6× 115 0.6× 46 0.4× 97 1.0× 126 1.3× 44 667
R. L. Carter United Kingdom 16 102 0.4× 76 0.4× 86 0.7× 59 0.6× 178 1.8× 23 573
Martin Birkhofer United States 9 371 1.5× 61 0.3× 57 0.5× 88 0.9× 186 1.9× 20 802

Countries citing papers authored by Richard M. Crapper

Since Specialization
Citations

This map shows the geographic impact of Richard M. Crapper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard M. Crapper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard M. Crapper more than expected).

Fields of papers citing papers by Richard M. Crapper

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard M. Crapper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard M. Crapper. The network helps show where Richard M. Crapper may publish in the future.

Co-authorship network of co-authors of Richard M. Crapper

This figure shows the co-authorship network connecting the top 25 collaborators of Richard M. Crapper. A scholar is included among the top collaborators of Richard M. Crapper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard M. Crapper. Richard M. Crapper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
2.
Merryman, Parvin, Peter K. Gregersen, Jack Silver, et al.. (1988). Nucleotide sequence of a DRw10 beta chain cDNA clone. Identity of the third D region with that of the DRw53 allele of the beta  2 locus and as the probable site encoding a polymorphic MHC class II epitope.. The Journal of Immunology. 140(7). 2447–2452. 46 indexed citations
3.
Begley, C. Glenn, et al.. (1987). Familial hairy cell leukemia. Leukemia Research. 11(11). 1027–1029. 13 indexed citations
4.
Crapper, Richard M., John P. Dowling, I. R. Mackay, & J. A. Whitworth. (1987). ACUTE SCLERODERMA IN STABLE MIXED CONNECTIVE TISSUE DISEASE: TREATMENT BY PLASMAPHERESIS. Australian and New Zealand Journal of Medicine. 17(3). 327–329. 13 indexed citations
5.
Crapper, Richard M., David Deam, & Lauren Grace Mackey. (1987). Paraproteinemias in Homosexual Men with HIV Infection: Lack of Association with Abnormal Clinical or Immunologic Findings. American Journal of Clinical Pathology. 88(3). 348–351. 41 indexed citations
6.
Frazer, Ian H., Richard M. Crapper, Gabriele Medley, Timothy C. Brown, & Lauren Grace Mackey. (1986). ASSOCIATION BETWEEN ANORECTAL DYSPLASIA, HUMAN PAPILLOMAVIRUS, AND HUMAN IMMUNODEFICIENCY VIRUS INFECTION IN HOMOSEXUAL MEN. The Lancet. 328(8508). 657–660. 158 indexed citations
7.
Crapper, Richard M., P. S. Bhathal, Lauren Grace Mackey, & Ian H. Frazer. (1986). ‘Acute’ Autoimmune Hepatitis. Digestion. 34(3). 216–225. 45 indexed citations
8.
Crapper, Richard M. & John W. Schrader. (1986). Evidence for the in vivo production and release into the serum of a T-cell lymphokine, persisting-cell stimulating factor (PSF), during graft-versus-host reactions.. PubMed. 57(4). 553–8. 10 indexed citations
9.
Frazer, Ian H., Lauren Grace Mackey, Richard M. Crapper, Ian D. Gust, & M. G. Sarngadharan. (1986). Prevalence of antibody to HTLV‐III in homosexual men in Melbourne. The Medical Journal of Australia. 144(5). 276–276. 3 indexed citations
10.
Schrader, John W., et al.. (1985). P-Cell Stimulating Factor: Biochemistry, Biology, and Role in Oncogenesis. PubMed. 10. 121–146. 4 indexed citations
11.
Crapper, Richard M., Ian Clark‐Lewis, & John W. Schrader. (1984). The in vivo functions and properties of persisting cell-stimulating factor.. PubMed. 53(1). 33–42. 21 indexed citations
12.
Crapper, Richard M., et al.. (1984). In vivo transfer of persisting (P) cells; further evidence for their identity with T-dependent mast cells.. The Journal of Immunology. 133(4). 2174–2179. 19 indexed citations
13.
Schrader, JW, et al.. (1984). In vitro approaches to lymphopoiesis, hemopoiesis, and oncogenesis.. PubMed. 18. 293–307. 1 indexed citations
14.
Burns, Gordon F., et al.. (1984). Activated lymphocyte killer cells derived from melanoma tissue or peripheral blood.. PubMed. 57(2). 487–94. 8 indexed citations
15.
Crapper, Richard M. & John W. Schrader. (1983). Frequency of mast cell precursors in normal tissues determined by an in vitro assay: antigen induces parallel increases in the frequency of P cell precursors and mast cells.. The Journal of Immunology. 131(2). 923–928. 85 indexed citations
16.
Schrader, John W. & Richard M. Crapper. (1983). Autogenous production of a hemopoietic growth factor, persisting-cell-stimulating factor, as a mechanism for transformation of bone marrow-derived cells.. Proceedings of the National Academy of Sciences. 80(22). 6892–6896. 73 indexed citations
17.
Schrader, John W., et al.. (1983). P‐cell Stimulating Factor: Characterization, Action on Multiple Lineages of Bone‐marrow‐derived Cells and Role in Oncogenesis. Immunological Reviews. 76(1). 79–104. 30 indexed citations
18.
Crapper, Richard M., Prithi S. Bhathal, & Lauren Grace Mackey. (1983). Chronic active hepatitis in alcoholic patients. Liver International. 3(5). 327–337. 23 indexed citations
19.
Crapper, Richard M.. (1981). FATAL AGRANULOCYTOSIS ATTRIBUTABLE TO CIMETIDINE. The Medical Journal of Australia. 2(5). 250–251. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by S Sugai Breakdown of academic impact, for papers by C. J. Alcock Breakdown of academic impact, for papers by A Puissant Breakdown of academic impact, for papers by M. Bunce Breakdown of academic impact, for papers by S. F. Goldmann Breakdown of academic impact, for papers by Lorraine Beldotti Breakdown of academic impact, for papers by Oettgen Hf Breakdown of academic impact, for papers by Mitsuo Okubo Breakdown of academic impact, for papers by R. L. Carter Breakdown of academic impact, for papers by Martin Birkhofer
Rankless by CCL
2026